Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,040 | 43 | 47.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $900.00 | 1 | 41.3% |
| Education | $238.57 | 3 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $981.29 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $387.93 | 13 | $0 (2024) |
| Amgen Inc. | $124.95 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $109.74 | 5 | $0 (2022) |
| Lilly USA, LLC | $88.57 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $76.33 | 3 | $0 (2024) |
| Celgene Corporation | $70.90 | 3 | $0 (2023) |
| Pharmacyclics LLC, an AbbVie Company | $57.97 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $56.94 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.83 | 3 | Daiichi Sankyo Inc. ($54.63) |
| 2023 | $203.75 | 7 | Lilly USA, LLC ($88.57) |
| 2022 | $1,408 | 18 | PFIZER INC. ($939.22) |
| 2021 | $489.63 | 19 | E.R. Squibb & Sons, L.L.C. ($177.26) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2023 | E.R. Squibb & Sons, L.L.C. | AUGTYRO (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Oncology | ||||||
| 11/14/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.42 | General |
| Category: Oncology | ||||||
| 10/11/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Oncology | ||||||
| 09/20/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $21.70 | General |
| 05/17/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: Hematology | ||||||
| 04/19/2023 | Lilly USA, LLC | VERZENIO (Drug) | Education | In-kind items and services | $88.57 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: ONC | ||||||
| 11/02/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $29.20 | General |
| Category: Oncology | ||||||
| 09/14/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 08/09/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Oncology | ||||||
| 07/27/2022 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: METABOLIC DISEASE | ||||||
| 07/18/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2022 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| 07/01/2022 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 06/02/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| 06/02/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $8.16 | General |
| 05/24/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Hematology | ||||||
| 05/03/2022 | PFIZER INC. | BOSULIF (Drug), RUXIENCE | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/12/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Oncology | ||||||
| 03/22/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Oncology | ||||||
| 03/09/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Oncology | ||||||
| 02/17/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hematology | ||||||
About Maryam Awan-Sen
Maryam Awan-Sen is a Medical healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1851942189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maryam Awan-Sen has received a total of $2,179 in payments from pharmaceutical and medical device companies, with $77.83 received in 2024. These payments were reported across 47 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,040).
Practice Information
- Specialty Medical
- Location New York, NY
- Active Since 09/27/2019
- Last Updated 07/31/2024
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851942189
Products in Payments
- OPDIVO (Biological) $174.32
- IMBRUVICA (Drug) $126.30
- Pomalyst (Drug) $125.00
- VERZENIO (Drug) $88.57
- KEYTRUDA (Biological) $56.94
- BOSULIF (Drug) $52.70
- REBLOZYL (Biological) $48.03
- DARZALEX (Biological) $41.41
- Enhertu (Drug) $29.97
- Cabometyx (Drug) $29.20
- LUMAKRAS (Drug) $25.95
- Trodelvy (Drug) $24.95
- Vanflyta (Drug) $24.66
- Sotyktu (Drug) $23.20
- Revlimid (Drug) $22.87
- ADCETRIS (Biological) $22.86
- Monoferric (Drug) $22.74
- MONJUVI (Drug) $21.01
- XPOVIO (Drug) $19.51
- Doptelet (Drug) $18.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in New York
Michele Kissous-Hunt, Pa, PA
Medical — Payments: $242,198
Laura Maroldo, Rpa-C, RPA-C
Medical — Payments: $113,742
Helen Adams, Pa-C, PA-C
Medical — Payments: $67,599
Hailey Brickman, Pa-C, PA-C
Medical — Payments: $40,927
Maria Baldo, Pa, PA
Medical — Payments: $34,901
Michael Querijero, Rpa-C, RPA-C
Medical — Payments: $32,014